Hartford Insurance Group (HIG) CEO Swift sells 201,938 shares after option exercise

Rhea-AI Filing Summary

Hartford Insurance Group Chairman and CEO Christopher Swift exercised 201,938 stock options at $48.89 per share and acquired the same number of common shares on February 2, 2026. He then sold 201,938 shares in multiple trades at weighted average prices between $135.04 and $137.14 per share under a Rule 10b5-1 trading plan adopted on November 3, 2025.

After these transactions, Swift directly holds 194,816.948 common shares and additional common stock indirectly through his spouse and the Swift Family Gift and Legacy Trusts. He also continues to hold several large stock option grants on Hartford common stock with expirations extending from 2027 through 2035.

Insider Trade Summary

Net Seller: 201,938 shares ($27,546,936)

Net Sell 19 txns

Insider Swift Christopher

Role Chairman and CEO

Sold 201,938 shs ($27.55M)

Type	Security	Shares	Price	Value
Exercise	Stock Option	201,938	$0.00	--
Exercise	Common Stock	201,938	$48.89	$9.87M
Sale	Common Stock	7,598	$137.0759	$1.04M
Sale	Common Stock	7,845	$137.0851	$1.08M
Sale	Common Stock	19,734	$135.5357	$2.67M
Sale	Common Stock	19,834	$135.5629	$2.69M
Sale	Common Stock	73,390	$136.5725	$10.02M
Sale	Common Stock	73,537	$136.5779	$10.04M
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option — 100,970 shares (Direct); Common Stock — 396,754.948 shares (Direct); Common Stock — 40,003 shares (Indirect, By Spouse)

Footnotes (1)

1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2017 and are scheduled to expire on February 28, 2027. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.14 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.13 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.89 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.93 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $136.04 - $137.03 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The options became fully exercisable on February 28, 2020, the third anniversary of the grant date. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Swift Christopher

(Last) (First) (Middle)

ONE HARTFORD PLAZA

(Street)

HARTFORD CT 06155

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HARTFORD INSURANCE GROUP, INC. [ HIG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/02/2026		M		201,938	A	$48.89	396,754.948	D
Common Stock	02/02/2026		S(1)		7,598	D	$137.0759(2)	389,156.948	D
Common Stock	02/02/2026		S(1)		7,845	D	$137.0851(3)	381,311.948	D
Common Stock	02/02/2026		S(1)		19,734	D	$135.5357(4)	361,577.948	D
Common Stock	02/02/2026		S(1)		19,834	D	$135.5629(5)	341,743.948	D
Common Stock	02/02/2026		S(1)		73,390	D	$136.5725(6)	268,353.948	D
Common Stock	02/02/2026		S(1)		73,537	D	$136.5779(6)	194,816.948	D
Common Stock								40,003	I	By Spouse
Common Stock								95,386	I	Swift Family Gift Trust
Common Stock								60,865	I	Swift Family Legacy Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$48.89	02/02/2026		M			201,938	(7)	02/28/2027	Common Stock	201,938	$0.0000	100,970	D
Stock Option	$49.01							(8)	02/26/2029	Common Stock	352,263		352,263	D
Stock Option	$51.87							(9)	02/23/2031	Common Stock	310,820		310,820	D
Stock Option	$53.81							(10)	02/27/2028	Common Stock	284,819		284,819	D
Stock Option	$55.27							(11)	02/25/2030	Common Stock	327,679		327,679	D
Stock Option	$69.41							(12)	02/23/2032	Common Stock	301,932		301,932	D
Stock Option	$78.28							(13)	02/28/2033	Common Stock	248,933		248,933	D
Stock Option	$95.74							(14)	02/27/2034	Common Stock	116,414		116,414	D
Stock Option	$116.41							(15)	02/25/2035	Common Stock	99,403		99,403	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a trading plan previously adopted by Mr. Swift on November 3, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The exercised options were granted to Mr. Swift in 2017 and are scheduled to expire on February 28, 2027.

2. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.14 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $137.04 - $137.13 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.89 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

5. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $135.04 - $135.93 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

6. Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $136.04 - $137.03 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

7. The options became fully exercisable on February 28, 2020, the third anniversary of the grant date.

8. The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.

9. The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.

10. The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.

11. The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.

12. The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.

13. One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.

14. One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.

15. One-third of the options will become exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.

	Anthony J. Salerno, Jr., Attorney-in-Fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HIG CEO Christopher Swift report on February 2, 2026?

Christopher Swift reported exercising 201,938 stock options at $48.89 per share and acquiring the same number of Hartford Insurance Group common shares. He then sold 201,938 shares in several market transactions, all disclosed in this insider ownership report filed for February 2, 2026.

At what prices did HIG CEO Christopher Swift sell his Hartford common shares?

Christopher Swift’s sales used weighted average prices, with disclosed ranges between $135.04 and $137.14 per share across different transaction groups. These prices reflect multiple trades, and he has committed to provide detailed per-trade pricing information upon request to regulators, the issuer, or security holders.

Was Christopher Swift’s HIG stock sale under a Rule 10b5-1 trading plan?

Yes. The filing states the reported transactions were effected under a trading plan Swift adopted on November 3, 2025, in accordance with Rule 10b5-1. Such plans pre-establish trading instructions, aiming to separate trading decisions from day-to-day, non-public information about the company’s business.

How many HIG common shares does Christopher Swift hold directly after these transactions?

Following the reported option exercise and share sales, Christopher Swift directly holds 194,816.948 Hartford Insurance Group common shares. This direct ownership figure is shown in the filing’s non-derivative securities table and reflects his remaining position after all February 2, 2026 transactions were completed.

What indirect ownership in HIG shares is reported for Christopher Swift?

Beyond his direct holdings, Swift reports indirect ownership of Hartford common stock through three relationships: 40,003 shares held by his spouse, 95,386 shares in the Swift Family Gift Trust, and 60,865 shares in the Swift Family Legacy Trust, as disclosed in the beneficial ownership table.

What stock options on HIG shares does Christopher Swift still hold after the exercise?

After exercising 201,938 options expiring February 28, 2027, Swift still holds multiple stock option grants on Hartford common stock. These remaining grants have exercise prices from $49.01 to $116.41 per share and expiration dates ranging from 2028 through 2035, with various vesting schedules detailed in footnotes.